Amdocs Research and Development Expense vs Consolidated Income Analysis

DOX
 Stock
  

USD 86.43  0.76  0.87%   

Amdocs financial indicator trend analysis is way more than just evaluating Amdocs Limited prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Amdocs Limited is a good investment. Please check the relationship between Amdocs Research and Development Expense and its Consolidated Income accounts. Continue to Investing Opportunities.

Research and Development Expense vs Consolidated Income

Research and Development Expense vs Consolidated Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Amdocs Limited Research and Development Expense account and Consolidated Income. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Amdocs' Research and Development Expense and Consolidated Income is 0.93. Overlapping area represents the amount of variation of Research and Development Expense that can explain the historical movement of Consolidated Income in the same time period over historical financial statements of Amdocs Limited, assuming nothing else is changed. The correlation between historical values of Amdocs' Research and Development Expense and Consolidated Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research and Development Expense of Amdocs Limited are associated (or correlated) with its Consolidated Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Consolidated Income has no effect on the direction of Research and Development Expense i.e., Amdocs' Research and Development Expense and Consolidated Income go up and down completely randomly.

Correlation Coefficient

0.93
Relationship DirectionPositive 
Relationship StrengthVery Strong

Research and Development Expense

A component of Operating Expenses representing the aggregate costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service.

Consolidated Income

The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of Net Income Available to Non-controlling Interests.
Most indicators from Amdocs fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Amdocs Limited current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Continue to Investing Opportunities.Amdocs Net Cash Flow Business Acquisitions and Disposals is fairly stable at the moment as compared to the past year. Amdocs reported Net Cash Flow Business Acquisitions and Disposals of 168.24 Million in 2021. Enterprise Value over EBIT is likely to rise to 15.21 in 2022, whereas Selling General and Administrative Expense is likely to drop slightly above 557.8 M in 2022.
 2019 2020 2021 2022 (projected)
Consolidated Income497.84 M688.37 M791.63 M673.75 M
Direct Expenses2.76 B2.81 B2.53 B2.34 B

Amdocs fundamental ratios Correlations

0.150.24-0.550.44-0.80.71-0.380.06-0.220.330.550.160.310.050.430.290.79-0.66-0.8
0.15-0.29-0.66-0.15-0.550.10.090.04-0.26-0.21-0.11-0.33-0.18-0.260.81-0.160.150.25-0.19
0.24-0.29-0.30.96-0.30.66-0.9-0.870.740.930.930.980.80.94-0.510.960.7-0.6-0.25
-0.55-0.66-0.3-0.50.94-0.70.460.340.01-0.33-0.53-0.24-0.21-0.26-0.43-0.44-0.680.160.68
0.44-0.150.96-0.5-0.530.8-0.92-0.80.620.890.980.940.750.89-0.340.960.81-0.63-0.43
-0.8-0.55-0.30.94-0.53-0.790.480.220.1-0.37-0.6-0.23-0.28-0.2-0.5-0.43-0.80.380.79
0.710.10.66-0.70.8-0.79-0.75-0.480.110.710.820.580.450.580.00.740.87-0.58-0.68
-0.380.09-0.90.46-0.920.48-0.750.85-0.67-0.86-0.88-0.87-0.69-0.860.26-0.91-0.780.510.3
0.060.04-0.870.34-0.80.22-0.480.85-0.85-0.85-0.74-0.84-0.73-0.870.43-0.83-0.550.320.06
-0.22-0.260.740.010.620.10.11-0.67-0.850.620.560.780.720.73-0.540.640.26-0.280.19
0.33-0.210.93-0.330.89-0.370.71-0.86-0.850.620.910.840.860.81-0.420.860.8-0.69-0.41
0.55-0.110.93-0.530.98-0.60.82-0.88-0.740.560.910.870.830.81-0.260.910.88-0.73-0.56
0.16-0.330.98-0.240.94-0.230.58-0.87-0.840.780.840.870.730.96-0.550.950.59-0.51-0.13
0.31-0.180.8-0.210.75-0.280.45-0.69-0.730.720.860.830.730.63-0.310.680.71-0.76-0.4
0.05-0.260.94-0.260.89-0.20.58-0.86-0.870.730.810.810.960.63-0.560.970.52-0.36-0.06
0.430.81-0.51-0.43-0.34-0.50.00.260.43-0.54-0.42-0.26-0.55-0.31-0.56-0.40.130.14-0.24
0.29-0.160.96-0.440.96-0.430.74-0.91-0.830.640.860.910.950.680.97-0.40.71-0.49-0.27
0.790.150.7-0.680.81-0.80.87-0.78-0.550.260.80.880.590.710.520.130.71-0.73-0.75
-0.660.25-0.60.16-0.630.38-0.580.510.32-0.28-0.69-0.73-0.51-0.76-0.360.14-0.49-0.730.59
-0.8-0.19-0.250.68-0.430.79-0.680.30.060.19-0.41-0.56-0.13-0.4-0.06-0.24-0.27-0.750.59
Click cells to compare fundamentals

Amdocs Account Relationship Matchups

Amdocs fundamental ratios Accounts

201720182019202020212022 (projected)
Receivables971.5 M987.86 M861.03 M866.82 M780.14 M737.36 M
Accounts Payable194.74 M176.51 M110.14 M121.2 M139.38 M156.14 M
Accumulated Other Comprehensive Income(32.73 M)(2.55 M)11.66 M9.34 M10.74 M11.59 M
Total Assets5.35 B5.29 B6.34 B6.51 B7.49 B7.04 B
Current Assets1.72 B1.68 B2.07 B2.07 B1.86 B1.85 B
Assets Non Current3.63 B3.62 B4.27 B4.44 B5.11 B4.59 B
Cash and Equivalents519.22 M471.63 M983.94 M965.59 M869.03 M894.22 M
Cash and Equivalents USD519.22 M471.63 M983.94 M965.59 M869.03 M894.22 M
Deferred Revenue132.41 M118.18 M126.84 M237.37 M272.98 M233.37 M
Shareholders Equity3.45 B3.5 B3.62 B3.59 B4.13 B4.14 B
Shareholders Equity USD3.45 B3.5 B3.62 B3.59 B4.13 B4.14 B
Goodwill and Intangible Assets2.71 B2.67 B2.87 B2.88 B3.31 B3.12 B
Total Liabilities1.86 B1.75 B2.68 B2.88 B3.31 B2.86 B
Current Liabilities1.29 B1.21 B1.22 B1.3 B1.5 B1.49 B
Liabilities Non Current560.82 M542.43 M1.46 B1.57 B1.81 B1.95 B
Trade and Non Trade Payables194.74 M176.51 M110.14 M121.2 M109.08 M116.65 M
Property Plant and Equipment Net496.58 M525.31 M903.45 M931.93 M1.07 B1.16 B
Trade and Non Trade Receivables971.5 M987.86 M861.03 M866.82 M996.84 M984.27 M
Accumulated Retained Earnings Deficit4.67 B5.01 B5.34 B5.85 B6.73 B5.93 B
Tax Liabilities224.57 M207.51 M258.49 M304.54 M274.08 M263.65 M

Amdocs Investors Sentiment

The influence of Amdocs' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Amdocs. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Amdocs' public news can be used to forecast risks associated with investment in Amdocs. The trend in average sentiment can be used to explain how an investor holding Amdocs can time the market purely based on public headlines and social activities around Amdocs Limited. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Amdocs' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Amdocs' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Amdocs' news discussions. The higher the estimate score, the more favorable is the investor's outlook on Amdocs.

Amdocs Implied Volatility

    
  25.39  
Amdocs' implied volatility exposes the market's sentiment of Amdocs Limited stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Amdocs' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Amdocs stock will not fluctuate a lot when Amdocs' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Amdocs in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Amdocs' short interest history, or implied volatility extrapolated from Amdocs options trading.

Pair Trading with Amdocs

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amdocs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amdocs will appreciate offsetting losses from the drop in the long position's value.

Moving together with Amdocs

0.61ADBEAdobe Systems Fiscal Year End 15th of December 2022 PairCorr
The ability to find closely correlated positions to Amdocs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amdocs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amdocs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amdocs Limited to buy it.
The correlation of Amdocs is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amdocs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amdocs Limited moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amdocs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Investing Opportunities. Note that the Amdocs Limited information on this page should be used as a complementary analysis to other Amdocs' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Complementary Tools for Amdocs Stock analysis

When running Amdocs Limited price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Is Amdocs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. If investors know Amdocs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amdocs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.089
Market Capitalization
10.7 B
Quarterly Revenue Growth YOY
0.088
Return On Assets
0.0605
Return On Equity
0.15
The market value of Amdocs Limited is measured differently than its book value, which is the value of Amdocs that is recorded on the company's balance sheet. Investors also form their own opinion of Amdocs' value that differs from its market value or its book value, called intrinsic value, which is Amdocs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amdocs' market value can be influenced by many factors that don't directly affect Amdocs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amdocs' value and its price as these two are different measures arrived at by different means. Investors typically determine Amdocs value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amdocs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.